Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_provenance.
- NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_assertion description "[Previous studies have reported FLT3 mutation in as many as 9.2% of myeloproliferative neoplasms (MPNs) and myelodysplastic/myeloproliferative neoplasms (MDS/MPNs), as well as in chronic myelogenous leukemia, that are negative for the JAK2 V617F gene mutation; no FLT3 mutation has been found in JAK2-positive MPNs, suggesting that the mutations are mutually exclusive.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_provenance.
- NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_assertion evidence source_evidence_literature NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_provenance.
- NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_assertion SIO_000772 23846442 NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_provenance.
- NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_assertion wasDerivedFrom befree-2016 NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_provenance.
- NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_assertion wasGeneratedBy ECO_0000203 NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_provenance.
- befree-2016 importedOn "2016-02-19" NP1093217.RAE6jIJVjH6Ps5cu0fN_XZDBmyt4ss1toZ_I-Xxh3BLto130_provenance.